Roberto Salvatore Bellia

Statistics

Publications

Citations

140

H-Index

Active since

2020

Affiliations

Istituto Ramazzini(Current)

Fondazione IRCCS Istituto Nazionale dei Tumori

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

European Institute of Oncology

University of Turin

Roberto Salvatore Bellia is an author at Istituto Ramazzini specializing in kidney cancer, renal cell carcinoma, and metastatic renal cell carcinoma therapy.

Publications per year

2020–2021

Publications

Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study

Cristina Masini, Cinzia Iotti, Ugo De Giorgi et al. · European Urology · 2021 · 105 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Nivolumab (NIVO) in combination with stereotactic body radiotherapy (SBRT) in pretreated patients (pts) with metastatic renal cell carcinoma (mRCC): First results of phase II NIVES study.

Cristina Masini, Cinzia Iotti, Ugo De Giorgi et al. · Journal of Clinical Oncology · 2020 · 35 citations

Medicine, Oncology, Radiation Oncology +17

1–2 of 2